Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSX:RVX - Post Discussion
Resverlogix Corp
> Interference
New Post
View:
Discussion
List
(7)
•••
Jesus4Prez
X
View Profile
View Bullboard History
Post by
Jesus4Prez
on Jan 09, 2022 4:04pm
Interference
Don mentioned 'interference' playing a part in the slow start of the Covid trial. It makes me wonder if they might opt not to report first dosing in order to stay under the radar, clear of interference?
J4P
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 10, 2022 8:41am
Don't think so, unforrunately. IR has confirmed to multiple people that we would be notified when dosing commenced.
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 15, 2022 10:12am
June/2021 News Release: “With EVERSANA’s integrated commercialization solution, we are poised to swiftly and efficiently deliver apabetalone to patients who desperately need it,” said Donald McCaffrey, President and CEO of Resverlogix. “We are proud to be on the front line with the global scientific medical community as we fight the ongoing threat of this and future pandemics.
...more
(2)
•••
toinv261
X
View Profile
View Bullboard History
Comment by
toinv261
on Jan 15, 2022 1:56pm
It is incredibly pitiful. As 10-41 just posted on Agora other biotechs are making inroads on Covid. I'm beginning to wonder if, because of Don's remarkable incompetence, RVX will ever achieve anything on any indication. The world is competitive and Covid has shown us the remarkable ability of thousands of bright biotech minds to innovate successfully. Don is old, uneducated and not
...more
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 16, 2022 11:24am
DM needs a Hail mary pass very very soon, what RVX needs if Covid results are stellar is a media /PR mass media warm room followed up a very large BP partnership , DM needs to realize if you can't beat them ie BP you need to join them,. BP control everything and Eversan is a good start but may be limited if they can't get a BP partnership deal IMO
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 17, 2022 9:53am
Priceless, Someone on the Agora board pointed out that one of the PIII advisory council members has been on CNN numerous times dicussing Covid. That's exactly the person we need to make up for IR's weakness. All we need is for him to be on a national US news station and be able to say that we have data proving RVX's effectiveness and we are off to the races. But WTF is
...more
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 17, 2022 10:28am
QT, yes I listened to the Dec webcast and CC, and someone on the RVX Covid cliical advisory team has been on CNN numerous times in the past few year. IMO RVX needs a BP partnership to get the market respect for valuation . Everything RVX has tried has not worked even after numrous fantastic peer reviwed publications on several indications plus EVersana partnership
...more
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 18, 2022 7:51am
We've got liftoff, Priceless!!!!! Best of luck to all that have stuck it out this long.
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 18, 2022 9:09am
QT If the initial results are good, with the FDA BTD, lets hope RVX gets a Emergency use authorization, that will get things moving
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 18, 2022 9:12am
Couldn't agree more. Am very interested to see if Eversana will be able to get this news on any Canadian channels tonight.
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 18, 2022 9:19am
If Eversana can get it on major news networsk, that will 100% light a fire under the stock.....!!
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 18, 2022 11:32am
Ottawa is busy attepting to negotiate oral pills from Merck and Pfizer!!,, JT will blow his load with BP. Probably little to nothing will be left for a lethargic no namer like RVX. Especially with our track record!!,,,,working around RVX is looked at like being in a sewer. Pinocchio will have 50 patients across the globe to show efficacy in this 2b, Talk about over powered,,,woooooow
...more
(95)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 18, 2022 12:30pm
narmac, let's hope this is not another false start for the open-label Phase 2b study of Apabetalone in Covid infection. Got my fingers crossed. All the best G1945V
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 18, 2022 6:45pm
GV,,,,,,lets hope is right,,,,,,the market is not putting any speculation into this company because of its inability to prove and provide sharevalue these past 20 years. Nothing will move the share price expept solid numbers of a sort,,something that has been shown to be out of reach for this management team. As Buffet always noted,,,buy the management team of a company who has proven track record
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 16, 2022 2:39pm
.,.,,accchhhh,,,Toinv,,,,,,DMcC,,is looked upon as a twin brother to Bernie Madoff,,,I see the resemblance,,,,,, :o) ,,,RVX is a disaster,,,,perhaps one for the record books for management incompentance!!!
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >